High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6.4M
$6,374,734
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Other
|
2026-02-11 | $297,000 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -43.8%
2026-02-11
$540,000
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -43.8%
|
2026-02-11 | $540,000 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
Director
Other
|
2026-01-15 | $287,210 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
Director
Discretionary SellΔOwn -14.7%
|
2026-01-15 | $530,531x2 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CEO
Sell to Cover
|
2026-01-08 | $638,504 | S | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Sell to Cover
2026-01-08
$163,192
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-08 | $163,192 | S | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Sell to CoverΔOwn -14.7%
2026-01-08
$98,809
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Sell to CoverΔOwn -14.7%
|
2026-01-08 | $98,809 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
Sell to CoverΔOwn -10.3%
|
2026-01-08 | $112,446 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CEO
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CEO
Sell to Cover
|
2026-01-07 | $415,102 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Equity Compensation
2026-01-07
$0
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Sell to Cover
2026-01-07
$100,821
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-07 | $100,821 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Equity Compensation
2026-01-07
$0
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Sell to Cover
2026-01-07
$439,200x4
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Sell to Cover
|
2026-01-07 | $439,200x4 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
Sell to Cover
|
2026-01-07 | $86,070 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CEO
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Equity Compensation
2026-01-06
$0
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Equity Compensation
2026-01-06
$0
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
Director
Discretionary SellΔOwn -28.8%
|
2025-12-23 | $193,342 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
Equity Compensation
2025-12-22
$27,750x2
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-22 | $27,750x2 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
Lizzul Paul F.
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-22
$75,000
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-22 | $75,000 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Equity Compensation
2025-12-22
$140,200x2
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Equity Compensation
|
2025-12-22 | $140,200x2 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -52.8%
2025-12-22
$510,000
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -52.8%
|
2025-12-22 | $510,000 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
Equity Compensation
|
2025-12-22 | $201,600x2 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
10b5-1 SellΔOwn -51.5%
|
2025-12-22 | $500,000 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
10b5-1 Sell
|
2025-12-18 | $6,626 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Equity Compensation
2025-12-17
$140,200x2
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Equity Compensation
|
2025-12-17 | $140,200x2 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -52.4%
2025-12-17
$460,000
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -52.4%
|
2025-12-17 | $460,000 | S | Form 4 |
|
ANAB
M
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
Equity Compensation
2025-12-16
$221,300x4
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Equity Compensation
|
2025-12-16 | $221,300x4 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -31.6%
2025-12-16
$560,800x2
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -31.6%
|
2025-12-16 | $560,800x2 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
Equity Compensation
|
2025-12-16 | $201,600x2 | M | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
CFO
10b5-1 SellΔOwn -37.3%
|
2025-12-16 | $705,333x2 | S | Form 4 |
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
Other
|
2025-09-30 | $70,100 | M | Form 4 |
|
ANAB
S
ANAPTYSBIO, INC
LOUMEAU ERIC J
• Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -47.5%
2025-09-30
$238,960
|
||||||
| ANAB |
ANAPTYSBIO, INC
|
Officer • CHIEF LEGAL OFFICER
10b5-1 SellΔOwn -47.5%
|
2025-09-30 | $238,960 | S | Form 4 |